Close collaboration to advance science
Dr. Markovic, center, collaborates on cancer research with Mayo Clinic colleagues Hu Zeng, Ph.D., left, and Yogish C. Kudva, M.B.B.S., right.
Overview
The Melanoma Research Laboratory of Svetomir N. Markovic, M.D., Ph.D., focuses on developing novel treatments for metastatic melanoma, for which treatment options are currently limited. Novel treatment modalities under exploration include immunotherapy, chemotherapy and nanomedicines.
Because melanoma is an immunogenic tumor, our lab is particularly interested in understanding the interaction of the immune system and the tumor. By gathering new insight about how melanoma tumors suppress the immune system to gain a growth advantage, we hope to more intelligently design new drugs or combine existing treatments for better options and outcomes.
The Melanoma Research Lab is affiliated with the Melanoma and Skin Cancer Research Program and the Mayo Clinic Cancer Center — Research.
About Dr. Markovic
A distinguished physician-scientist, Dr. Markovic has received numerous awards and recognitions during his career. In addition to being principal investigator of the Melanoma Research Lab, Dr. Markovic is an oncologist and a hematologist at Mayo Clinic in Rochester, Minnesota. Dr. Markovic specializes in treating patients with advanced and metastatic melanoma, with a particular interest in immunologic therapy.